Lectures and discussion groups covering: mechanisms and methodologies in cancer immunology and immunotherapy, drug development, aspects of clinical translation, and career development.
Winter School features:
Every participant will have the opportunity to give an oral presentation and show a poster of their work.
Program devotes ample time for thorough discussion of participants’ projects with all speakers and faculty.
Speakers and faculty will share their experience in combining science and entrepreneurship in an exciting and fast-moving field.
Time for one-on-one conversations offers participants exclusive networking opportunities to fuel their careers.
Application and call for abstracts:
Applications are open for post-docs and advanced PhD students. Interested scientists must submit a scientific abstract, a CV, and a letter of intent which describes their academic and professional goals and projects.
Please send all required documents to email@example.com by December 15, 2019.
The 7th Immunotherapy of Cancer Conference (ITOC7) to be held in Munich, Germany from April 2 – 4, 2020 is a European meeting providing a global platform for translational research in the field of immuno-oncology as well as a forum for discussion of early clinical translation and to address its unique challenges.
ITOC7 is organised by the WMA GmbH in scientific cooperation with the ITOC Association, the Tumor Centre in Munich (TZM), the Society for Immunotherapy of Cancer (SITC), the German Cancer Consortium (DKTK) as well as the Comprehensive Cancer Center Munich (CCCM) in Munich.
The main goal of the series of ITOC conferences is to provide a unique platform for discussions where all those dedicated to the immunotherapy of cancer can exchange their knowledge and latest findings to advance the oncology drug development and delivery.
Meeting Chairs: Michel C. Nussenzweig, M.D., Ph.D. and Jeffrey V. Ravetch, M.D., Ph.D, Rockefeller University.
Theme: New Dimensions of Therapeutic Antibodies.
Annual Kunkel Memorial Lecturer: Tadatsugu Taniguchi, PhD, University of Tokyo who will be speaking about advances in the treatment of inflammatory diseases and cancer.
The AACR Annual Meeting program covers the latest discoveries across the spectrum of cancer research—from population science and prevention; to cancer biology, translational, and clinical studies; to survivorship and advocacy—and highlights the work of the best minds in research and medicine from institutions all over the world.
ICoMI 2020 Congress is a forceful and up-to-date platform where open-minded discussions will promote networking between researchers, clinicians, students and all persons involved in the development of science and medicine. It will be a great opportunity to let new creative and innovative ideas make new collaborations and highlight the latest technology that will help us to reduce the time to find new medication or combinations of treatment especially in the field of chronic diseases.
Antibody Industrial Symposium AIS2020 jointly organized by the scientific society LabEx MAbImprove
and MabDesign, the French association of the Immunotherapy Industrial sector, will be held the 22nd and 23rd of June 2020 in Montpellier. This year edition will focus on a major theme chosen by the Scientific Advisory Board: “Multispecific Abs, Ab-like molecules and adoptive cell therapy for fighting diseases”. It includes keynote lectures, pitch talks around new creative projects, and industrial talks from big pharmaceutical companies.
Moreover, the program will allow opportunities for networking, companies to showcase their new products and technologies as well as dedicated time for business partnering.
Hosted by Arthur L. Irving Family Foundation, this symposium/workshop will focus on advancing the careers of young scientists in cancer immunology. Fifteen accomplished faculty mentors will share their research career experience in cancer immunology with ~40 promising young scientists (post-docs, advanced graduate students and starting faculty). Participants will learn how excellent science can be advanced by formulating questions, designing and executing studies to address these questions, hiring, mentoring, collaborating, leadership, raising funds, and publishing. Sessions will include lectures, small discussion/working groups with faculty mentors on specific topics, and review sessions to integrate lessons learned. Participants will also work on updating their research statement to support their next stage of career development. Applicants will be selected by a committee based on the applicant’s research achievements and plans, and recommendations by their mentors. Applications are due by Feb 15, 2020 and participants will be informed of acceptance in March 2020.
The ESMO Congress is the most influential oncology platform in Europe for clinicians, researchers, patient advocates, journalists and the pharmaceutical industry from all over the world. ESMO Congress 2020 will present the very latest advances in oncology and translate science into better cancer patient care.
The ESMO Congress 2020 programme will be developed by a committee composed of more than 300 international experts under the leadership of Scientific Chair Prof John Haanen, NKI Amsterdam, Netherlands, a leading expert in the field of immunotherapy.